Female Reproductive Tract Organ-on-Chips: Modeling Barrier Function and Drug Transport.

Area of Science:

• Biomedical Engineering
• Reproductive Biology
• Drug Delivery Systems

Background:

• Female reproductive tract (FRT) disorders pose a significant global health challenge.
• Historically, women's health and FRT-targeted therapies have been underfunded in research and development.
• Understanding drug transport across FRT barriers is crucial for developing effective treatments.

Purpose of the Study:

• To review anatomical and physiological barriers of the FRT.
• To discuss design considerations for developing FRT-on-chip models.
• To highlight advanced organ-on-chip (OoC) applications in FRT research.

Main Methods:

• Review of existing literature on FRT physiology and OoC technology.
• Analysis of OoC platforms designed to mimic FRT microenvironments.
• Discussion of design principles for FRT-on-chip models.

Main Results:

• Conventional in vitro and animal models fail to replicate human FRT complexity.
• OoC platforms integrate human cells with controlled perfusion to recreate physiological conditions.
• Current OoC models are being developed to study FRT infections, drug permeation, and hormonal responses.

Conclusions:

• FRT-on-chip models represent a significant advancement over traditional research methods.
• These models have the potential to improve preclinical drug screening and toxicity evaluation.
• Future integration with immune components and vascularization will enhance their predictive power for personalized medicine.